Ökat söktryck hos Emea

Stockholm-Uppsala life science cluster in brief

Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.

Nytt system hanterar sekvenseringsdata

Dagens avancerade tekniker för sekvensering av DNA gör att det behövs nya system för att lagra de enorma mängder data som samlas. På Uppmax i Uppsala finns ett resurscentrum som hanterar merparten genetiska data från Uppsala universitet.

Antikropp mot p53 i zebrafisk.

Anaspec lanserar en ny antikropp specifik för p53 från zebrafisk.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Prestigepris till norsk cancerforskare

Tilldelas ett femårigt mångmiljonstöd från det europeiska forskningsrådet ERC.

Kliniskt diagnostest för sjukhussjukan

LightCycler MRSA Advanced Test från Roche testar förekomsten av MRSA, som orsakar det som allmänt kallas för sjukhussjukan.

Tigran får fransk order

Genom partnerbolaget Advanced Medical Products har Tigran tagit i sin hittills största order sedan försäljningsstarten ifjol.

AMO får nya ägare

Abbott köper Advanced Medical Optics som byter namn till Abbott Medical Optics.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Dupont gets new business manager

The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Transatlantic cooperation for healthier food

Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.